FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2996661504> ?p ?o ?g. }

• W2996661504 abstract "Therapeutically restricted sites present a formidable barrier in medicine. Herein, chemical strategies to overcome two restricted sites, HIV reservoirs and intracellular bacteria, will be discussed. First, cellular and anatomical HIV reservoirs, such as those in the brain, limit HIV eradication using currently known therapeutic regimes. HIV therapies are unable to localize in the brain, in part, due to high expression of efflux transporters, such as P-glycoprotein (P-gp), at the BBB, because many of these therapies are P-gp substrates. In an effort to overcome therapeutically restricted HIV sanctuaries, a dimerized combination HIV therapy was designed to act two-fold. First, the dimeracts as a P-gp inhibitor allowing therapeutic access to restricted sites. Second, the dimeractsas a prodrug, which once in the reducing environment of the cell, may release monomeric HIV therapies. The dual conjugate, Abacavir-S2-Darunavir, was shown to potently inhibit P-gp across two separate cell lines, was able to regenerate the component monomers in a reducing environment and contained modest anti-HIV activity.Further, mammalian cells create sanctuary sites for bacteria to grow and proliferate, because many common antibiotic therapies are unable to cross the mammalian cell membrane. Therefore, these pathogens are able to proliferate without therapeutic constraint. Here, a chemical strategy was developed to deliver a dual antibiotic therapy inside mammalian cells in an effort to clear these intracellular pathogens. First, a new synthetic strategy was developed for facile synthesis of dual conjugates, composedof an aminoglycoside and a cell penetrating peptide (CPP) linked with a reversible disulfide tether, using kanamycin and the known CPP Arg8as a model system. Next, this synthetic methodology was expanded for use with theaminoglycoside tobramycin and theknown broad-spectrum antibiotic and cell penetrating peptide, P14LRR, once again linked via the reversible disulfide tether (TobP14). Two distinct isomers of TobP14 were synthesized, isolated, and fully characterized by 2D NMR. The TobP14 isomers were shown to be an effective antibiotic across various Gram positive and negative pathogens such as MRSA, S. epidermidis, P. aeruginosa, and A. baumannii. Further, the isomers effectively releasedthe monomeric therapies (tobramycin and P14-SH) in a reducing environment and werenontoxic to mammalian cells up to 16 μM. Finally, the dual conjugate isomers significantly reduce two different strains of intracellular A. baumanniiwithin macrophages." @default.
• W2996661504 created "2019-12-26" @default.
• W2996661504 creator A5073982664 @default.
• W2996661504 date "2019-11-28" @default.
• W2996661504 modified "2023-09-24" @default.
• W2996661504 title "Designing Chemical Strategies to Promote Therapeutic Access to Restricted Sites In Cyto" @default.
• W2996661504 doi "https://doi.org/10.25394/pgs.11285030.v1" @default.
• W2996661504 hasPublicationYear "2019" @default.
• W2996661504 type Work @default.
• W2996661504 sameAs 2996661504 @default.
• W2996661504 citedByCount "0" @default.
• W2996661504 crossrefType "dissertation" @default.
• W2996661504 hasAuthorship W2996661504A5073982664 @default.
• W2996661504 hasConcept C108215921 @default.
• W2996661504 hasConcept C1491633281 @default.
• W2996661504 hasConcept C185592680 @default.
• W2996661504 hasConcept C200082930 @default.
• W2996661504 hasConcept C55493867 @default.
• W2996661504 hasConcept C79879829 @default.
• W2996661504 hasConcept C86803240 @default.
• W2996661504 hasConcept C95444343 @default.
• W2996661504 hasConceptScore W2996661504C108215921 @default.
• W2996661504 hasConceptScore W2996661504C1491633281 @default.
• W2996661504 hasConceptScore W2996661504C185592680 @default.
• W2996661504 hasConceptScore W2996661504C200082930 @default.
• W2996661504 hasConceptScore W2996661504C55493867 @default.
• W2996661504 hasConceptScore W2996661504C79879829 @default.
• W2996661504 hasConceptScore W2996661504C86803240 @default.
• W2996661504 hasConceptScore W2996661504C95444343 @default.
• W2996661504 hasLocation W29966615041 @default.
• W2996661504 hasOpenAccess W2996661504 @default.
• W2996661504 hasPrimaryLocation W29966615041 @default.
• W2996661504 hasRelatedWork W1488348146 @default.
• W2996661504 hasRelatedWork W1502175951 @default.
• W2996661504 hasRelatedWork W1965951065 @default.
• W2996661504 hasRelatedWork W1970918177 @default.
• W2996661504 hasRelatedWork W2026361605 @default.
• W2996661504 hasRelatedWork W2030611694 @default.
• W2996661504 hasRelatedWork W2033637003 @default.
• W2996661504 hasRelatedWork W2036388244 @default.
• W2996661504 hasRelatedWork W2036627421 @default.
• W2996661504 hasRelatedWork W2096336250 @default.
• W2996661504 hasRelatedWork W2329069643 @default.
• W2996661504 hasRelatedWork W2425923052 @default.
• W2996661504 hasRelatedWork W2726009964 @default.
• W2996661504 hasRelatedWork W2767896595 @default.
• W2996661504 hasRelatedWork W2791867191 @default.
• W2996661504 hasRelatedWork W2922433765 @default.
• W2996661504 hasRelatedWork W3004303301 @default.
• W2996661504 hasRelatedWork W59456145 @default.
• W2996661504 hasRelatedWork W65117547 @default.
• W2996661504 hasRelatedWork W2198893624 @default.
• W2996661504 isParatext "false" @default.
• W2996661504 isRetracted "false" @default.
• W2996661504 magId "2996661504" @default.
• W2996661504 workType "dissertation" @default.